2nd Quarter - Report

COREWELL HEALTH for COREWELL HEALTH

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health system financial challenges. Drug discount program under section 340B of the Public Health Service Act. Efforts to support America's healthcare workers and address the workforce shortage. Development of AI policies and regulations.

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Site neutral policies Medicare Telehealth Reimbursement Medicare DSH Payment

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

340B PBM Reform/Oversight Transparency and high costs associated with prescription drugs

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Labor Issues/Antitrust/Workplace LBR

Workforce Shortage within Healthcare Industry S. 3744 Health ACCESS Act Talent Pipeline Attract, train, retain

LobbyistCovered position, as disclosed
KRISTINA KO —
PHILIP D YEITER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3744 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.